Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Genetics · Hereditary Breast and Ovarian Cancer

How Do I Prepare a Family Cancer History for Genetics?

At a Glance

To prepare for a genetic counselor, gather a three-generation family health history from both your mother's and father's sides. Focus on the primary cancer type, age at diagnosis, and age at death for each relative. Even an incomplete family history is extremely helpful for assessing your risk.

When you schedule an appointment with a genetic counselor to discuss your risk for Hereditary Breast and Ovarian Cancer (HBOC) syndrome, their first tool will be your family tree. To accurately assess your genetic risk, you need to provide a three-generation family health history including cancer types, ages at diagnosis, and ages of death for relatives on both sides of your family [1][2][3].

Please know this upfront: It is incredibly common for families to have lost touch or kept health details secret. Do not panic if your family tree has gaps. Gathering this information is not a test you can fail. Just collect whatever you comfortably can—even a partial history is immensely helpful [4][5].

Mapping Three Generations

A complete family history, often called a pedigree, looks at patterns of disease across three generations [1][2]. It is a common misconception that breast or ovarian cancer risk only passes down through the mother’s side. In reality, you can inherit a cancer-risk gene from either your mother or your father, making both lineages equally critical for your risk assessment [6][7].

When gathering names and information, try to include the following first-, second-, and third-degree relatives [7]:

  • First-degree: Your parents, siblings, and children.
  • Second-degree: Your grandparents, aunts, uncles, nieces, nephews, and half-siblings.
  • Third-degree: Your first cousins and great-grandparents.

The Details to Collect

For every relative who has had cancer, try to gather the following details. If you don’t know the exact answers, that is okay—just bring what you know.

  • Primary cancer site: Try to find out exactly where the cancer started [5]. For instance, clarify vague terms like “female cancer” or “womb cancer.” Distinguishing between cervical cancer, uterine cancer, and ovarian cancer is very important because ovarian cancer is a hallmark of HBOC [8][5]. If you only know a relative had “stomach cancer,” simply report that. If a relative already has copies of their pathology reports on hand, those are fantastic “bonuses” to share with your counselor, but you do not need to go on a scavenger hunt for them [4][9].
  • Age at diagnosis: Note how old your relative was when they were first told they had cancer [3].
  • Current age or age at death: Record their current age if they are living, or the exact age and cause of death if they have passed away [5]. If a family member happens to have a death certificate, it can act as a helpful bonus for verifying information [9].
  • Prior genetic testing: Ask if anyone in your family has ever had genetic testing for cancer risk [9]. If they have, try to find out when they were tested and see if they can share a copy of their lab report. Older tests may have only checked for BRCA1 and BRCA2, missing other important genes that we know about today [10][11].

Important Clues for HBOC

While preparing your history, pay special attention to certain red flags that are strongly linked to HBOC and mutations in genes like BRCA1 and BRCA2 [12]. Make sure to highlight if your family history includes:

  • Specific cancer types: Aside from breast cancer, HBOC is linked to elevated risks for ovarian cancer, pancreatic cancer, aggressive prostate cancer, and melanoma [13][12]. An ovarian cancer diagnosis at any age is considered a significant red flag [14][5].
  • Young or rare breast cancers: Note any cases of breast cancer diagnosed before age 50, male breast cancer, or triple-negative breast cancer (a specific subtype often linked to BRCA1 mutations) [15][14].
  • Multiple primary cancers: Mark down if a single relative was diagnosed with two completely different, new cancers (like breast cancer in both breasts, or both breast and ovarian cancer) [3].
  • Ashkenazi Jewish ancestry: Individuals with Eastern European (Ashkenazi) Jewish ancestry have a significantly higher chance of carrying certain BRCA mutations, so be sure to mention this heritage if it applies to either side of your family [14].

Having the Conversation

Talking about cancer and passing away can be difficult for many families. Approach the conversation gently, perhaps explaining that you are putting together a family health tree for your own preventative care. Writing things down in a notebook or using a family history questionnaire can help you stay organized and make the process feel more manageable [16]. Ultimately, your genetic counselor will use whatever information you can provide to tailor the best possible care plan for you [4][9].

Common questions in this guide

Do I only need to gather cancer history from my mother's side of the family?
Yes, you can inherit a cancer-risk gene from either your mother or your father. Both lineages are equally critical, so you should gather health information for relatives on both sides of your family.
What if I don't know my full family cancer history?
Do not panic if your family tree has gaps or if health details were kept secret. Collecting this information is not a test, and your genetic counselor will use whatever partial history you can comfortably provide to tailor your care plan.
How many generations should I include in my family cancer history?
A complete family history looks at patterns of disease across three generations. Try to include first-degree relatives like parents and siblings, second-degree relatives like grandparents and aunts, and third-degree relatives like cousins and great-grandparents.
What specific details do I need to find out about a relative's cancer?
If a relative had cancer, try to find out the primary cancer site (where it started), their age when first diagnosed, and their current age or age at death. It is also very helpful to know if they ever had prior genetic testing for cancer risk.
What cancer red flags should I look for in my family tree?
Significant red flags include ovarian cancer at any age, male breast cancer, and breast cancer diagnosed before age 50. Other important clues include multiple primary cancers in one person, triple-negative breast cancer, and Ashkenazi Jewish ancestry.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the family history I have gathered, do I meet the national guidelines for genetic testing?
  2. 2.Are there specific relatives in my pedigree whose medical records or pathology reports I should prioritize tracking down?
  3. 3.Given my family's specific mix of cancers, should we look beyond the standard BRCA genes and consider a larger multi-gene panel?
  4. 4.If my family history is limited or unknown, how does that change your approach to my risk assessment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Validation of a guidelines-based digital tool to assess the need for germline cancer genetic testing.

    Russell CD, Daley AV, Van Arnem DR, et al.

    Hereditary cancer in clinical practice 2024; (22(1)):24 doi:10.1186/s13053-024-00298-0.

    PMID: 39516903
  2. 2

    Role of family history and clinical screening in the identification of families with idiopathic dilated cardiomyopathy in Johannesburg, South Africa.

    Bailly C, Henriques S, Tsabedze N, Krause A

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2019; (109(9)):673-678 doi:10.7196/SAMJ.2019.v109i9.13936.

    PMID: 31635593
  3. 3

    Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.

    Morgan RD, Burghel GJ, Flaum N, et al.

    Journal of medical genetics 2019; (56(5)):301-307 doi:10.1136/jmedgenet-2018-105792.

    PMID: 30683677
  4. 4

    Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.

    Darooei M, Poornima S, Salma BU, et al.

    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017; (39(2)):1010428317694303 doi:10.1177/1010428317694303.

    PMID: 28231738
  5. 5

    Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.

    Greenberg S, Buys SS, Edwards SL, et al.

    Cancer medicine 2019; (8(15)):6789-6798 doi:10.1002/cam4.2534.

    PMID: 31531966
  6. 6

    Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting.

    Lin J, Wolfe I, Ahsan MD, et al.

    Gynecologic oncology reports 2022; (40()):100941 doi:10.1016/j.gore.2022.100941.

    PMID: 35242980
  7. 7

    A detailed family history of myocardial infarction and risk of myocardial infarction--a nationwide cohort study.

    Ranthe MF, Petersen JA, Bundgaard H, et al.

    PloS one 2015; (10(5)):e0125896 doi:10.1371/journal.pone.0125896.

    PMID: 26011129
  8. 8

    Should the risk for uterine cancer influence decision making for prophylactic hysterectomy in BRCA1/2 mutated patients- a systematic review and meta-analysis.

    Nahshon C, Segev Y, Gemer O, et al.

    Gynecologic oncology 2021; (160(3)):755-762 doi:10.1016/j.ygyno.2020.11.034.

    PMID: 33309051
  9. 9

    Importance of family history and indications for genetic testing.

    Wood ME, Rehman HT, Bedrosian I

    The breast journal 2020; (26(1)):100-104 doi:10.1111/tbj.13722.

    PMID: 31865627
  10. 10

    Molecular Features and Clinical Management of Hereditary Gynecological Cancers.

    Ueki A, Hirasawa A

    International journal of molecular sciences 2020; (21(24)) doi:10.3390/ijms21249504.

    PMID: 33327492
  11. 11

    Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome.

    Yoo J, Lee GD, Kim JH, et al.

    Annals of laboratory medicine 2020; (40(2)):148-154 doi:10.3343/alm.2020.40.2.148.

    PMID: 31650731
  12. 12

    Five Italian Families with Two Mutations in BRCA Genes.

    Vietri MT, Caliendo G, D'Elia G, et al.

    Genes 2020; (11(12)) doi:10.3390/genes11121451.

    PMID: 33287145
  13. 13

    Exploring Breast Cancer Risk Management in HBOC Patients: Image Surveillance Versus Risk-reducing Surgery.

    Seki T, Kobayashi Y, Masuda K, et al.

    The Keio journal of medicine 2025; (74(3)):130-137 doi:10.2302/kjm.2024-0021-RE.

    PMID: 40175132
  14. 14

    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

    , Owens DK, Davidson KW, et al.

    JAMA 2019; (322(7)):652-665 doi:10.1001/jama.2019.10987.

    PMID: 31429903
  15. 15

    A novel germline BRCA1 mutation identified in a family with hereditary breast and ovarian cancer syndrome.

    Wu Y, Pan X, Dou J, et al.

    Clinical Medicine Insights. Oncology 2021; (15()):11795549211028569 doi:10.1177/11795549211028569.

    PMID: 34276234
  16. 16

    UK recommendations for the management of transgender and gender-diverse patients with inherited cancer risks.

    Giblin J, Coad B, Lamb C, et al.

    BJC reports 2023; (1(1)):1 doi:10.1038/s44276-023-00002-0.

    PMID: 39516684

This page is for informational purposes only and does not replace professional medical advice. Always consult your genetic counselor or healthcare provider about your specific family history and genetic risk.

Get notified when new evidence is published on Hereditary breast and/or ovarian cancer syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.